Table 1 Description of Quality-Assured ACT classifications

Definitions

Government recommended first-line treatments (regardless of strength) for uncomplicated malaria that appear on the WHO list of approved ACTs or the UNICEF procurement records.

Brands on these lists and audited in each country were:

ACTs that are not the government's recommended first-line treatment for uncomplicated malaria, but which appear on the WHO list of approved ACTs or the UNICEF procurement records.

Brands on these lists and audited in each country were:

Benin

Artefan 20/120; Coartem; Lumartem 20/120; Lumet 20/120

Coarsucam; Winthrop

DRC

Arsuamoon; Artesunate & Amodiaquine from Ipca; Artesunate & Amodiaquine from Cipla; Falcimon Kit; Serenadose; Coarsucam; Winthrop

Artefan 20/120; Coartem 20/120; Lumartem 20/120

Madagascar

Arsuamoon; Artesunate & Amodiaquine from Ipca; Actipal 50/153; Winthrop; Coarsucam; Falcimon kit; Larimal

Artefan 20/120; Coartem 20/120;

Coartem D 20/120;

Lumartem 20/120

Nigeria

Coartem 20/120; Coartem D 20/120; Lumerax 20/120 *Arsuamoon; *Coarsucam; *Larimal

Artecospe

Uganda

Coartem; Artefan 20/120; Lumartem 20/120

Larimal, Falcimon kit

Zambia

Artefan 20/120; Coartem 20/120; Lumartem 20/120; Lumerax; Lumet 20/120

Arsuamoon; Artecospe